Latest Breaking News On - Xylocor therapeutics inc - Page 1 : comparemela.com

XyloCor Therapeutics Presents Phase 2 Data Highlighting Safety and Efficacy of XC001 at the European Society of Cardiology (ESC) Congress 2023

WAYNE, PA. (BUSINESS WIRE) Aug 25, 2023

United statesAl gianchettiA brian davisTodd rosengartThomas povsicMike beyerCornell universitySam brown incDuke university school of medicineXylocor therapeutics incEuropean society of cardiologyHealthcare communicationsNational principal investigatorCor therapeuticsEuropean societyPrincipal investigator

Refractory Angina Market to Increase at a 7 97% CAGR During the Study Period [2018-2030], Speculates DelveInsight

Refractory Angina Market to Increase at a 7 97% CAGR During the Study Period [2018-2030], Speculates DelveInsight
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomDelveinsight levodopaPrnewswire delveinsightAngionetics incCaladrius biosciences incMarket companiesJacobus pharmaceuticalsXylocor therapeutics incImbria pharmaceuticalsJacobus pharmaceutical company incMarket researchBusiness consulting servicesRefractory anginaAngina marketCaladrius biosciences